Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q2 2025 (June 30)6holders +1
2new positions
1sold out
$0.12avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were Toronto Dominion Bank ($271K), Walleye Capital LLC ($70K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($31K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $271K |
| Exits | 1 | $133 |
All 13F filers, Q1 2025 → Q2 2025: 2,170,322 shares bought and 1,304 shares sold, net +2,169,018 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Toronto Dominion Bank | — | New | 2,170,272 | $271K |
| Walleye Capital LLC | — | No change | 560,061 | $70K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $31K |
| Zazove Associates LLC | — | No change | 65,456 | $6K |
| Walleye Trading LLC | — | No change | 34,142 | $4K |
| IFP Advisors, Inc | — | New | 50 | $4 |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.